GO:0007507 heart development: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0007507 heart development describes the progression of the heart from formation to mature structure, including the hollow muscular organ that contracts rhythmically to circulate blood.
• Heart development is driven by conserved molecular mechanisms shared between Drosophila and vertebrates, making model organisms powerful for discovery.
• Wnt signaling is a central regulatory axis in cardiac development, and its dysregulation is linked to congenital heart disease and impaired regeneration.
• MicroRNAs and m6A RNA modification add posttranscriptional layers of control over cardiac gene expression during development.
• Growth, hypoxia, and metabolic cues shape fetal heart development, and perturbations can program adult cardiovascular disease.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of cardiac developmental genes in vitro and in vivo.
Description
Heart development (GO:0007507) is the biological process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ that contracts rhythmically to maintain blood circulation, and its correct development is essential for survival. Researchers study this process to understand congenital heart defects, cardiac regeneration, and the molecular programs that build a functional organ. The process is highly conserved: molecular mechanisms of heart development in Drosophila and vertebrates share deep homology, which allows findings from simple models to inform human cardiac biology. At the core of heart development are signaling pathways, transcription factor networks, and posttranscriptional regulators that coordinate cell specification, morphogenesis, and maturation. Wnt signaling, for example, is repeatedly implicated in cardiac development and heart disease, making it a major research focus. In addition, microRNAs and RNA modifications such as m6A fine-tune the timing and dosage of cardiac gene expression. Environmental and physiological inputs, including growth and hypoxia, also influence fetal heart development and can have lasting consequences for cardiac health. Because heart development is a multi-step process, researchers need robust experimental systems to dissect each stage and to test causality of candidate genes.
heart development At A Glance
| GO ID | GO:0007507 |
|---|---|
| GO term | heart development |
| Ontology | biological_process |
| Synonym | cardiac development; dorsal vessel development |
| Definition | The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure; the heart is a hollow, muscular organ that contracts rhythmically to circulate blood. |
| Major function | Building a functional heart through conserved molecular and cellular mechanisms. |
| Key regulatory pathways | Wnt signaling, microRNA networks, m6A RNA modification, growth and hypoxia responses. |
| Model organisms | Drosophila and vertebrates, including zebrafish, chick, and mouse, are used to study conserved mechanisms. |
| Disease relevance | Congenital heart defects, cardiac regeneration failure, and adult heart disease. |
What Is GO:0007507?
GO:0007507 heart development is defined as the process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ that, by contracting rhythmically, keeps up the circulation of the blood. This term encompasses the full developmental trajectory, including early specification of cardiac progenitors, formation of the primitive heart tube, looping and chamber formation, and maturation into a functional organ. It also includes the molecular and cellular events that regulate these steps, such as signaling pathway activity, transcriptional control, and posttranscriptional regulation. Synonyms for this term include cardiac development and dorsal vessel development, reflecting its conservation across species.
Why Is heart development Important in Cell Biology?
Heart development is important because it determines the structural and functional integrity of the heart, and defects in this process are a major cause of congenital heart disease and lifelong cardiovascular risk. Understanding the molecular mechanisms of heart development also informs efforts to regenerate damaged myocardium, since pathways active during development are often reactivated or dysregulated in disease. Moreover, conserved mechanisms between Drosophila and vertebrates provide a framework for identifying core cardiac regulators that can be tested in higher organisms. Posttranscriptional regulators such as microRNAs and m6A modification further highlight that heart development is not only a transcriptional program but also a tightly controlled RNA-level process. Physiological inputs like growth and hypoxia during fetal life can program the heart for adult disease, underscoring the clinical importance of developmental windows.
• Heart development is essential for forming a hollow, muscular organ that circulates blood.
• Defects in heart development contribute to congenital heart disease and pediatric cardiac morbidity.
• Wnt signaling is a central pathway in cardiac development and is implicated in heart disease and regeneration.
• MicroRNAs regulate cardiac gene expression and are required for normal heart development.
• m6A RNA modification adds a posttranscriptional layer of control in heart development and disease.
• Growth and hypoxia during fetal life influence heart development and can program adult cardiac disease.
• Conserved molecular mechanisms between Drosophila and vertebrates make model organisms valuable for cardiac research.
• Understanding heart development supports strategies for cardiac regeneration and repair.
• Developmental pathways are often reactivated in cardiac pathology, making them therapeutic targets.
• CRISPR-based models allow causal testing of genes involved in heart development.
What Happens During heart development?
Cardiac specification and early patterning
In simple terms: Early in development, a subset of cells is told to become heart cells.
Heart development begins with the specification of cardiac progenitor cells, a process governed by conserved signaling and transcriptional programs. Wnt signaling is a key regulator of cardiac specification and early patterning, influencing whether progenitors expand or differentiate. Comparative studies in Drosophila and vertebrates show that core molecular mechanisms of cardiac specification are evolutionarily conserved. Disruption of these early steps can lead to structural heart defects.
Formation of the heart tube and looping
In simple terms: The early heart cells organize into a tube that then twists into shape.
After specification, cardiac progenitors organize into a primitive heart tube, which subsequently undergoes looping and chamber formation. These morphogenetic events require coordinated changes in cell shape, adhesion, and gene expression. Wnt signaling continues to play a role in patterning and morphogenesis during this phase. Defects in tube formation or looping are associated with congenital heart malformations.
Chamber formation and maturation
In simple terms: The tube becomes a multi-chambered pump ready to circulate blood.
Chamber formation involves regionalized gene expression and growth, leading to the mature heart structure that contracts rhythmically to circulate blood. Growth signals and physiological cues, including hypoxia, influence chamber maturation and myocardial growth. MicroRNAs fine-tune gene expression programs required for proper chamber development. Perturbations in these maturation steps can result in functional deficits and disease.
Posttranscriptional control of cardiac gene expression
In simple terms: After genes are turned on, RNA-level controls decide how much protein is made.
MicroRNAs regulate cardiac gene expression during heart development by repressing target mRNAs. In addition, m6A RNA modification has emerged as a novel posttranscriptional regulator in heart development and disease. These mechanisms ensure precise timing and dosage of cardiac proteins. Dysregulation of posttranscriptional control can contribute to cardiac pathology.
Conserved molecular mechanisms across species
In simple terms: Fruit flies and vertebrates build hearts using many of the same molecular tools.
Heart development in Drosophila and vertebrates shares conserved molecular mechanisms, including signaling pathways and transcription factors. This conservation allows researchers to use model organisms to identify core cardiac regulators. Wnt signaling is one such conserved pathway with roles in cardiac development and disease. Comparative approaches can reveal fundamental principles of heart formation.
Key Genes Involved in GO:0007507 heart development
The following genes and pathways are central to heart development and are frequently studied in cardiac research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| WNT3A | Wnt signaling ligand in cardiac development | Studied for roles in cardiac specification and disease |
| CTNNB1 | Wnt signaling effector (beta-catenin) | Key node in cardiac development and regeneration |
| MIR1-1 | MicroRNA regulating cardiac gene expression | Required for normal heart development |
| MIR133A1 | MicroRNA controlling cardiac proliferation | Implicated in cardiac development and disease |
| METTL3 | m6A RNA methyltransferase | Regulates posttranscriptional control in heart development |
| METTL14 | m6A RNA methyltransferase complex component | Modulates cardiac RNA modification |
| YTHDF1 | m6A reader protein | Influences cardiac mRNA fate |
| NKX2-5 | Cardiac transcription factor | Essential for heart development and chamber formation |
| GATA4 | Cardiac transcription factor | Regulates cardiac gene expression and morphogenesis |
| TBX5 | Transcription factor in heart development | Linked to cardiac septation and conduction |
| MEF2C | Transcription factor in cardiac muscle | Controls cardiac differentiation and maturation |
| HAND1 | Basic helix-loop-helix transcription factor | Required for cardiac morphogenesis |
| HAND2 | Basic helix-loop-helix transcription factor | Involved in cardiac chamber development |
| MYH6 | Cardiac myosin heavy chain | Marker of cardiomyocyte maturation |
| ACTC1 | Cardiac actin | Structural component of the heart |
| TNNT2 | Cardiac troponin T | Regulates cardiac contraction |
| VEGFA | Angiogenic factor | Supports cardiac vascularization during development |
How Is heart development Regulated?
Heart development is regulated by multiple layers of control. Wnt signaling acts as a central regulatory pathway, with distinct roles at different stages of cardiac development and in heart disease. MicroRNAs provide posttranscriptional regulation by repressing target mRNAs, thereby shaping cardiac gene expression programs. m6A RNA modification adds another regulatory layer by influencing mRNA stability, translation, and fate. Physiological inputs such as growth and hypoxia also modulate heart development, and these cues can have lasting effects on cardiac structure and function. Together, these regulatory mechanisms ensure that heart development proceeds with precise spatial and temporal control.
heart development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NKX2-5 | Congenital heart disease | Knockout or point-mutation in cardiomyocytes |
| GATA4 | Cardiac septation defects | Knock-in of patient variants |
| TBX5 | Holt-Oram syndrome | Knockout and rescue models |
| CTNNB1 | Cardiac development and regeneration | Overexpression and knockout in cardiac progenitors |
| METTL3 | m6A-related cardiac dysfunction | Knockout and overexpression in cardiomyocytes |
Congenital heart disease
Disruptions in heart development can lead to congenital heart defects, which are among the most common birth anomalies. Wnt signaling dysregulation has been implicated in cardiac developmental disorders and heart disease. Mutations in cardiac transcription factors such as NKX2-5, GATA4, and TBX5 are associated with structural heart malformations. Understanding these developmental pathways is essential for diagnosis and potential therapeutic intervention.
Cardiac regeneration and repair
Pathways active during heart development, such as Wnt signaling, are often reactivated or modulated during cardiac regeneration attempts. MicroRNAs and m6A regulators that control developmental gene expression may also influence regenerative capacity. Research into heart development therefore informs strategies to promote cardiac repair after injury.
Fetal programming of adult heart disease
Growth and hypoxia during fetal heart development can program the heart for adult cardiovascular disease. The developmental environment influences myocardial growth and maturation, with long-term consequences. This highlights the importance of understanding heart development not only for birth defects but also for adult disease prevention.
From heart development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for cardiac specification? | CRISPR knockout in cardiac progenitor cells |
| Does a patient variant cause developmental defects? | Point-mutation knock-in in cardiomyocytes |
| Can a developmental gene be tagged for localization? | Tagged knock-in (e.g., GFP) in cardiac cells |
| Does overexpression of a pathway gene alter heart development? | Overexpression cell model |
| Which genes regulate cardiac maturation? | CRISPR library screening in differentiating cardiomyocytes |
| What are the transcriptomic changes during heart development? | RNA-seq and bioinformatics analysis |
How to Study the heart development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression | Profiling heart development stages |
| MicroRNA profiling | MicroRNA expression levels | Studying posttranscriptional regulation |
| m6A mapping | RNA modification sites | Investigating epitranscriptomic control |
| CRISPR knockout | Gene function loss | Testing requirement in cardiac development |
| CRISPR point mutation | Specific variant effects | Modeling patient variants |
| CRISPR knock-in | Tagged or reporter alleles | Tracking protein localization |
| Overexpression | Gain-of-function effects | Testing pathway activation |
Transcriptomic profiling
RNA-seq can capture global gene expression changes during heart development and in response to genetic perturbations. This approach helps identify pathways and gene networks involved in cardiac specification and maturation. Bioinformatics analysis of transcriptomic data can reveal candidate regulators for further study.
Posttranscriptional and epitranscriptomic analysis
MicroRNA profiling and m6A mapping are used to study posttranscriptional regulation in heart development. These methods reveal how RNA-level control shapes cardiac gene expression. Integrating these data with transcriptomics provides a more complete picture of cardiac regulatory networks.
Functional genomics with CRISPR
CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of genes in heart development. Library screening can identify novel regulators of cardiac differentiation and maturation. These functional approaches complement observational transcriptomic studies.
Imaging and phenotyping
Imaging of cardiac structures and contractility is used to assess developmental outcomes in model systems. Phenotypic analysis can reveal morphological and functional defects. Combining imaging with molecular readouts provides a comprehensive view of heart development.
How CRISPR Can Be Used to Study GO:0007507 heart development
Knockout
CRISPR knockout is used to delete candidate genes and assess their requirement in heart development. This approach can reveal essential roles in cardiac specification, morphogenesis, and maturation. Knockout models are foundational for causal gene discovery in cardiac biology.
Point Mutation
Point-mutation knock-in allows modeling of specific patient variants in cardiac genes. This approach tests whether a single nucleotide change is sufficient to alter heart development. It is valuable for validating variant pathogenicity in congenital heart disease.
Knock-in
Tagged knock-in (e.g., fluorescent or epitope tags) enables visualization and biochemical analysis of cardiac proteins. This helps track localization, interactions, and dynamics during heart development. Knock-in reporters can also be used for lineage tracing.
Overexpression
Overexpression models test gain-of-function effects of cardiac genes and pathways. They are useful for studying Wnt signaling activation and other developmental pathways. Overexpression can reveal sufficiency of a gene to drive or disrupt heart development.
How EDITGENE Supports heart development Research
Researchers studying heart development-related genes often need to determine whether a candidate gene is causally involved in cardiac specification, morphogenesis, or maturation. Observational data from transcriptomics and pathway analysis can nominate targets, but functional validation requires precise genetic perturbation. CRISPR-based models provide the tools to test loss-of-function, gain-of-function, and specific variant effects in relevant cardiac cell systems.
Contact EDITGENE today to design your custom CRISPR model for heart development research.
Frequently Asked Questions About heart development
What is GO:0007507 heart development?
GO:0007507 heart development is the biological process describing the progression of the heart from formation to mature structure, including the hollow muscular organ that contracts rhythmically to circulate blood.
What genes are involved in heart development?
Key genes include cardiac transcription factors such as NKX2-5, GATA4, and TBX5, as well as signaling pathway components like CTNNB1 and posttranscriptional regulators such as METTL3.
How does Wnt signaling regulate heart development?
Wnt signaling is a central pathway in cardiac development, influencing specification, patterning, and morphogenesis, and its dysregulation is linked to heart disease.
What is the role of microRNAs in heart development?
MicroRNAs regulate cardiac gene expression posttranscriptionally and are required for normal heart development.
How does m6A modification affect heart development?
m6A RNA modification adds a posttranscriptional layer of control in heart development and disease, influencing mRNA fate.
Why are Drosophila and vertebrates used to study heart development?
Conserved molecular mechanisms between Drosophila and vertebrates allow findings from simple models to inform human cardiac biology.
How do growth and hypoxia influence fetal heart development?
Growth and hypoxia during fetal life shape heart development and can program adult cardiovascular disease.
What experimental models are used to study heart development?
Models include CRISPR knockout, point-mutation, knock-in, and overexpression cell systems, as well as RNA-seq and imaging approaches.
What diseases are linked to defects in heart development?
Congenital heart disease, cardiac regeneration failure, and fetal programming of adult heart disease are linked to heart developmental defects.
How can CRISPR help study heart development genes?
CRISPR enables knockout, point-mutation, knock-in, and overexpression models to causally test genes in heart development.
Conclusion
Heart development (GO:0007507) is a conserved, multi-step biological process that builds a hollow, muscular organ capable of rhythmic contraction and blood circulation. Its regulation involves Wnt signaling, microRNAs, m6A modification, and physiological cues such as growth and hypoxia. Defects in heart development underlie congenital heart disease and influence adult cardiac health, making this process a major research focus. CRISPR-based functional models provide powerful tools to dissect the causal roles of cardiac genes and to advance therapeutic strategies.
References
- 1. Horitani K et al.. 2024. Wnt signaling in cardiac development and heart diseases.. In Vitro Cell Dev Biol Anim 60(5):482-488 PMID: 38709417
- 2. Anderson PA. 1996. The heart and development.. Semin Perinatol 20(6):482-509 PMID: 9090776
- 3. Li D et al.. 2022. Wnt Signaling in Heart Development and Regeneration.. Curr Cardiol Rep 24(10):1425-1438 PMID: 35925512
- 4. Espinoza-Lewis RA et al.. 2012. MicroRNAs in heart development.. Curr Top Dev Biol 100:279-317 PMID: 22449848
- 5. Bodmer R et al.. 1998. Heart development in Drosophila and vertebrates: conservation of molecular mechanisms.. Dev Genet 22(3):181-6 PMID: 9621426
- 6. Li D et al.. 2025. m(6)A and cardiac posttranscriptional regulation: a novel player in heart development and disease.. Exp Mol Med 57(9):1893-1901 PMID: 40887502
- 7. Thornburg KL et al.. 2008. The role of growth in heart development.. Nestle Nutr Workshop Ser Pediatr Program 61:39-51 PMID: 18196943
- 8. Patterson AJ et al.. 2010. Hypoxia and fetal heart development.. Curr Mol Med 10(7):653-66 PMID: 20712587
